Live Earnings Conference Call: Liquidia Technologies will host a live Q2 2025 earnings call on August 12, 2025 at 8:30AM ET. Follow this link to get details and listen to Liquidia Technologies' Q2 2025 earnings call when it goes live. Get details. Liquidia Technologies (LQDA) Competitors $21.20 +0.75 (+3.67%) Closing price 08/11/2025 04:00 PM EasternExtended Trading$24.00 +2.80 (+13.21%) As of 07:50 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LQDA vs. IRTC, GKOS, BLCO, SLNO, TMDX, INSP, NVST, PRCT, WRBY, and LIVNShould you be buying Liquidia Technologies stock or one of its competitors? The main competitors of Liquidia Technologies include iRhythm Technologies (IRTC), Glaukos (GKOS), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), TransMedics Group (TMDX), Inspire Medical Systems (INSP), Envista (NVST), PROCEPT BioRobotics (PRCT), Warby Parker (WRBY), and LivaNova (LIVN). These companies are all part of the "medical equipment" industry. Liquidia Technologies vs. Its Competitors iRhythm Technologies Glaukos Bausch + Lomb Soleno Therapeutics TransMedics Group Inspire Medical Systems Envista PROCEPT BioRobotics Warby Parker LivaNova Liquidia Technologies (NASDAQ:LQDA) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, risk, institutional ownership, media sentiment, earnings, valuation, dividends and analyst recommendations. Do analysts rate LQDA or IRTC? Liquidia Technologies currently has a consensus price target of $26.89, suggesting a potential upside of 26.83%. iRhythm Technologies has a consensus price target of $157.30, suggesting a potential downside of 2.03%. Given Liquidia Technologies' higher probable upside, equities research analysts plainly believe Liquidia Technologies is more favorable than iRhythm Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Liquidia Technologies 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.00iRhythm Technologies 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 3.00 Do insiders and institutionals have more ownership in LQDA or IRTC? 64.5% of Liquidia Technologies shares are held by institutional investors. 30.1% of Liquidia Technologies shares are held by company insiders. Comparatively, 0.7% of iRhythm Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is LQDA or IRTC more profitable? iRhythm Technologies has a net margin of -14.06% compared to Liquidia Technologies' net margin of -903.80%. iRhythm Technologies' return on equity of -90.03% beat Liquidia Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Liquidia Technologies-903.80% -177.91% -60.15% iRhythm Technologies -14.06%-90.03%-8.52% Which has more risk & volatility, LQDA or IRTC? Liquidia Technologies has a beta of 0.14, suggesting that its share price is 86% less volatile than the S&P 500. Comparatively, iRhythm Technologies has a beta of 1.41, suggesting that its share price is 41% more volatile than the S&P 500. Does the media favor LQDA or IRTC? In the previous week, iRhythm Technologies had 5 more articles in the media than Liquidia Technologies. MarketBeat recorded 13 mentions for iRhythm Technologies and 8 mentions for Liquidia Technologies. iRhythm Technologies' average media sentiment score of 0.63 beat Liquidia Technologies' score of 0.61 indicating that iRhythm Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Liquidia Technologies 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive iRhythm Technologies 8 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation & earnings, LQDA or IRTC? iRhythm Technologies has higher revenue and earnings than Liquidia Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Liquidia Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLiquidia Technologies$14M129.46-$130.39M-$1.58-13.42iRhythm Technologies$591.84M8.72-$113.29M-$2.93-54.80 SummaryiRhythm Technologies beats Liquidia Technologies on 9 of the 16 factors compared between the two stocks. Get Liquidia Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for LQDA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LQDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LQDA vs. The Competition Export to ExcelMetricLiquidia TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.75B$3.00B$5.48B$9.72BDividend YieldN/A2.28%4.59%4.13%P/E Ratio-13.4217.0529.7624.63Price / Sales129.46347.15453.92102.60Price / CashN/A40.7324.8127.99Price / Book23.308.898.595.76Net Income-$130.39M-$54.75M$3.26B$264.95M7 Day Performance5.63%-2.71%-0.34%-0.01%1 Month Performance50.46%4.43%2.12%1.27%1 Year Performance73.63%19.64%44.64%26.11% Liquidia Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LQDALiquidia Technologies3.8064 of 5 stars$21.20+3.7%$26.89+26.8%+82.0%$1.75B$14M-13.4250Gap DownIRTCiRhythm Technologies1.9502 of 5 stars$164.98+0.0%$157.30-4.7%+126.2%$5.30B$591.84M-56.312,000GKOSGlaukos3.9632 of 5 stars$87.52+1.6%$127.42+45.6%-28.5%$4.92B$383.48M-53.04780Positive NewsBLCOBausch + Lomb2.8213 of 5 stars$13.76+1.9%$15.56+13.0%-13.2%$4.78B$4.79B-17.6413,500SLNOSoleno Therapeutics4.5644 of 5 stars$84.12-2.2%$108.70+29.2%+86.8%$4.33BN/A-18.2130Earnings ReportAnalyst RevisionTMDXTransMedics Group2.4841 of 5 stars$128.50+6.6%$123.00-4.3%-21.9%$4.11B$441.54M66.58210Gap UpINSPInspire Medical Systems4.631 of 5 stars$130.79+3.7%$208.55+59.5%-58.8%$3.72B$802.80M60.271,246Buyback AnnouncementGap UpHigh Trading VolumeNVSTEnvista3.4004 of 5 stars$20.48-1.7%$20.92+2.2%+24.8%$3.46B$2.51B63.9912,300PRCTPROCEPT BioRobotics3.4151 of 5 stars$49.60-0.7%$84.13+69.6%-36.6%$2.76B$249.12M-29.18430Trending NewsEarnings ReportAnalyst UpgradeAnalyst RevisionWRBYWarby Parker2.0338 of 5 stars$24.47+3.7%$23.13-5.5%+76.6%$2.47B$771.32M-203.883,780LIVNLivaNova2.2342 of 5 stars$42.76+4.0%$59.29+38.6%+12.8%$2.24B$1.25B-10.452,900Earnings ReportAnalyst Upgrade Related Companies and Tools Related Companies iRhythm Technologies Competitors Glaukos Competitors Bausch + Lomb Competitors Soleno Therapeutics Competitors TransMedics Group Competitors Inspire Medical Systems Competitors Envista Competitors PROCEPT BioRobotics Competitors Warby Parker Competitors LivaNova Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LQDA) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredSell these stocks now—what to buy insteadWall Street veteran Marc Chaikin—creator of the Power Gauge system—is warning that “smart money” is rapidly pu...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liquidia Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Liquidia Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access